ACN Newswire
Read More

EC Healthcare Announced Strategic Alliance with Prudential

indie
4 minutes

HONG KONG, Feb 13, 2023 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group formed partnership with Prudential Hong Kong Limited ("Prudential") to jointly offer tailored and value-added healthcare services, enabling customers to achieve their health and wealth ambition. Through this partnership, customers of Prudential can enjoy exclusive offer on bivalent vaccination service provided by EC Healthcare via online reservation platform, amongst many other healthcare services.EC Healthcare has been developing a one-stop, multi-disciplinary, enclosed healthcare service platform and positioning strategic collaboration with insurance giants as a crucial part of the Group's core strategy. Benefiting from the long-stand leading brand and the comprehensive healthcare services provided under the unique one-stop healthcare ecosystem, the Group formed a strategic partnership with Prudential based on mutual trust, further enriching the Group's vertically integrated healthcare ecosystem. With the shar...

ACN Newswire
Read More

EC Healthcare Expects Third Quarter FY23 Sales Volume to Increase no less than 8% YoY

indie
4 minutes

HONG KONG, Jan 20, 2023 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group expects sales volume for the period of October to December 2022 (the "Quarter") to increase by no less than 8% as compared with the same period last year.The demand on medical services provided by the Group remains strong and the Group's increasingly diversified business demonstrated resilience and good momentum. The Board expects to record overall sales volume of no less than HK$1,000 million for the Quarter, representing a no less than 8% YoY increase. The Group expects to achieve a no less than 39% YoY increase for medical services sales volume. Sales volume of aesthetic medical and beauty and wellness services in Hong Kong and Macau declined by no more than 17% YoY, while sales volume of aesthetic medical and beauty and wellness services in Mainland China declined by no more than 50% YoY during the Quarter. The decrease in aesthetic medical and beauty and wellness services was mainly due to (i) weaker local ...

ACN Newswire

BeautyFarm Med, the largest provider of traditional beauty services in China Successfully Listed on the Main Board of SEHK

indie
3 minutes

HONG KONG, Jan 17, 2023 - (ACN Newswire via SEAPRWire.com) - Beauty Farm Medical and Health Industry Inc. ("BeautyFarm Med" or "Company", stock code: 2373.HK), the largest provider of traditional beauty services in China in term of revenue in 2021, successfully listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today, with a board lots of 500 shares each. The stock price of BeautyFarm Med reached HK$30.5 at its debut today, representing an increase of 57.9% over the offer price. The share price closed at HK$29.65, up 53.5% and represents a market capitalization of HK$ 6.83billion.Morgan Stanley Asia Limited, Haitong International Capital Limited and Huatai Financial Holdings (Hong Kong) Limited are the Joint Sponsors to the global offering; Morgan Stanley Asia Limited, Haitong International Securities Company Limited and Huatai Financial Holdings (Hong Kong) Limited are the Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Managers to the global offering.The Company states that the listing of BeautyFarm Med in Hong Kong marks a key milestone and unfolds a new chapter in the Company's development. Looking ahe...

JCN Newswire
Read More

Fujitsu and Sapporo Medical University launch joint project to realize data portability in the healthcare field

ruth
8 minutes

TOKYO, Jan 16, 2023 - (JCN Newswire via SEAPRWire.com) - Fujitsu and Sapporo Medical University today announced the launch of a joint project starting in April 2023 to realize data portability (1) for patients' healthcare data including electronic health records (EHRs) (2) and personal health records (PHRs) (3).Image 1: Overview of the initiativeImage 2: App screen image (in Japanese)As part of the joint project, Fujitsu will develop a mobile app that enables users to view healthcare data on their iPhones (4) and a cloud-based healthcare data platform to manage patients' health data. This project marks the first initiative in Japan to link electronic medical records with Apple's Health app under Apple's support.EHR data stored on the newly developed external healthcare data platform will be converted to a format in accordance with JP Core (FHIR JP Core Implementation Guide Version 1.1.1) (5), the latest Japanese guideline under the next generation standards framework HL7 FHIR for health information exchange.By empowering patients to access their medical data from anywhere at any time and play a more active role in managing their own health, the project aims to contribute to the pro...

ACN Newswire

Beauty Farm Medical and Health Industry Inc. Announces Proposed Listing on the Main Board of SEHK, Offer price at HK$19.32 per share

indie
9 minutes

HONG KONG, Dec 30, 2022 - (ACN Newswire via SEAPRWire.com) - Beauty Farm Medical and Health Industry Inc. ("Beauty Farm" or "Company", stock code: 2373), the largest provider of traditional beauty services in China, today announces the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK").Beauty Farm plans to offer an aggregate of 40,536,500 Offer Shares under the Global Offering (subject to the Over-allotment Option), consisting of 36,482,500 International Offer Shares (subject to reallocation and the Over-allotment Option) and 4,054,000 Hong Kong Offer Shares (subject to reallocation), at a price of HK$19.32 per share.The Company will start its public offering in Hong Kong at 9 a.m. on 30 December, 2022 (Friday) and end at 12 noon on 6 January, 2023 (Friday). Dealings in shares on SEHK are expected to commence on 16 January 2023 (Monday), with the stock code of 2373 in board lots of 500 shares each.Morgan Stanley Asia Limited, Haitong International Capital Limited and Huatai Financial Holdings (Hong Kong) Limited are the Joint Sponsors; Morgan Stanley Asia Limited, Haitong International Securities Company Limited and Huatai Financial...

JCN Newswire
Read More

TANAKA Contributes to Venture Capital Fund “DMC No. 1 Investment Limited Partnership” Aiming to Establish a Medical Venture Ecosystem in Japan

ruth
7 minutes

TOKYO, Dec 20, 2022 - (JCN Newswire via SEAPRWire.com) - TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which operates the TANAKA Precious Metals manufacturing business, announced today that it has made an equity contribution to the medical venture capital fund Diamond Medino Capital (DMC) No. 1 Investment Limited Partnership founded in Japan by Professor Terumitsu Hasebe (Professor, Faculty of Medicine, School of Medicine, Tokai University; Visiting Professor, Keio University School of Medicine; Visiting Professor, Massachusetts Institute of Technology/Harvard Medical School; medical doctor, PhD in Medicine, and PhD in Engineering). This is Japan's first medical venture capital fund established with an active medical professor serving as its representative. Through this equity contribution, TANAKA Kikinzoku Kogyo will contribute toward technological development in Japan's domestic medical and healthcare industry.Background and ObjectivesTANAKA Kikinzoku Kogyo decided to undertake this equity contribution as the company supports the fund's principle of establishing a medical venture ecosystem originating from Japan....

ACN Newswire
Read More

SinoMab Awarded the “Most Valuable Pharmaceutical and Medical Company” in the Selection of the “7th Hong Kong Golden Stocks Awards”

indie
7 minutes

HONG KONG, Dec 19, 2022 - (ACN Newswire via SEAPRWire.com) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Company was awarded the "Most Valuable Pharmaceutical and Medical Company" at the "7th Hong Kong Golden Stocks Awards Ceremony" held in Hangzhou today.The Company Awarded the "Most Valuable Pharmaceutical and Medical Company"The "Most Valuable Pharmaceutical and Medical Company" award aims to recognize Hong Kong-listed pharmaceutical and medical companies that have a healthy corporate governance structure, prominent industry status, sound governance structure, good main business, and the ability to provide investors with sustainable and stable values. SinoMab was awarded the "Most Valuable Pharmaceutical and Medical Company", highlighting the attention and recognition of the industry and investors on the Company's value and innovation capabilities, which is a great encouragement and even a sp...

ACN Newswire
Read More

EC Healthcare wins “Best in Healthcare Sector” at IR Magazine's Greater China Awards 2022

indie
3 minutes

HONG KONG, Dec 14, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, is pleased to announce the Group has garnered the "Best in Healthcare Sector" at IR Magazine's Greater China Awards 2022.IR Magazine has honored excellence in investor relations around the world with awards which recognize companies that are leading the way for the IR community. This award is determined by the input of hundreds of analysts and portfolio managers, who give their opinions on which companies provide them with the best IR service. Winning this award showcases the Group's commitment to upholding the highest standard of investor relations and carries the weight of recognition from the entire investment community.Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "The Group is honored to receive the "Best in Healthcare Sector" from IR Magazine Awards - Greater China 2022. This prestige Award demonstrates the recognition of our Group's efforts to achieve excellences in corporate governance, investo...

ACN Newswire
Read More

Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEX

indie
12 minutes

HONG KONG, Dec 13, 2022 - (ACN Newswire via SEAPRWire.com) - OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, has today announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX"). The Group intends to offer an aggregate of 54,633,000 shares, of which 49,169,000 shares will be for the International Offering (subject to reallocation) and 5,464,000 shares will be for the Hong Kong Public Offering (subject to reallocation). The offer price is HK$8.80 per Offer Share. The estimated net proceeds from the Global Offering will amount to approximately HK$366.8 million, after deducting underwriting commissions and other estimated expenses paid and payable by the Group in connection with the Global Offering.Investment Highlights-- Headquartered in the Hong Kong Science Park, OrbusNeich is a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percut...

JCN Newswire
Read More

Olympus Announces Launch of Olympus Asia Pacific Innovation Program

ruth
5 minutes

SINGAPORE, Dec 5, 2022 - (JCN Newswire via SEAPRWire.com) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, has partnered with MedTech Innovator Asia Pacific, the industry's largest healthcare accelerator, to facilitate the Olympus Asia Pacific Innovation Program (OAIP) running throughout 2023.Over a century old, Olympus has a rich heritage in the field of medical device innovation, having made a substantial impact on lives, with a portfolio of solutions that provide treatment for approximately 100[1] diseases or conditions, including the top four[2] of five cancers by global incidence rates. Olympus believes that the emergence of new technologies, particularly those within the digital realm, will revolutionize the patient care paradigm. Patient outcomes will be improved by optimizing the care pathway for individual patients based on their unique needs.Olympus invites visionary startups to contribute to this revolution by participating in the OAIP and submitting their technologies that play a meaningful role in the advancement of minimally invasive care and new ways to detect, monitor, and treat condit...

ACN Newswire
Read More

EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly Driven by Medical Services

indie
9 minutes

HONG KONG, Nov 24, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its unaudited interim results for the six months ended 30 September 2022 (the "Period").Business Highlight -- Total revenue increased by 31.1% YoY to HK$1,893.2 million-- Revenue from medical services segment rose by 47.5% YoY to HK$1,174.8 million, boosting its revenue contribution to 62.1%-- Revenue from aesthetic medical and beauty and wellness services segment decreased by 2.0% YoY to HK$607.4 million, accounted for approximately 32.1% of total revenue-- Driven by previous acquired veterinary business, revenue from other services increased by 301.9% YoY to HK$111.0 million, represents 5.8% of the total revenue-- Organic revenue(1) increased by 22.8% YoY to HK$1,773.7 million, accounting for 93.7% of the total-- EBITDA during the period was HK$269.9 million-- Net profit after tax for during the period was HK$105.2 million-- Basic earnings per share during the period amounted to 6.8 HK cents-- The Board declared an interim dividend ...

ACN Newswire

Perfect Medical Announces Interim Results for FY2022/23

indie
5 minutes

HONG KONG, Nov 23, 2022 - (ACN Newswire via SEAPRWire.com) - Perfect Medical Health Management Limited (the "Company" , Stock Code: 1830.HK), one of the largest aesthetic medical operators in the world, together with its subsidiaries (collectively referred to as the "Group"), is pleased to announce its interim results for the six months ended 30 September 2022.RESULTS HIGHLIGHTS-- The Group's revenue decreased by 16.6% to HK$668.3 million, impacted by Covid-19 pandemic causing suspension of 20 days in Hong Kong, 39 days in Macau, as well a business disruption for an average of 14 days, 23 days, 63 days and 19 days across Guangzhou, Shenzhen, Shanghai and Beijing respectively.-- The second quarter marked a 52.1% growth in revenue quarter-on-quarter in Hong Kong following the ease of Covid-19 pandemic.-- The Group's EBITDA decreased by 25.5% to HK$229.7 million.-- The Group's net profit decreased by 30.4% to HK$150.7 million, representing the net profit margin of 22.5%. Basic earnings per share was HK12.1 cents.-- The Board recommends the payment of an interim dividend of HK13.0 cents per share, representing a dividend payout ratio of 107.4%.-- The Group operated a total of 307,000 s...

JCN Newswire
Read More

To Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research

ruth
4 minutes

TOKYO, Nov 22, 2022 - (JCN Newswire via SEAPRWire.com) - Shimadzu Corporation (Shimadzu), Eisai Co., Ltd. (Eisai), Oita University, and Usuki City Medical Association hereby announce the commencement of a cohort study using Usuki City as a demonstration site. This joint study will attempt to develop Japan's first diagnostic workflow for mild cognitive impairment (MCI) and Alzheimer's disease (AD) that uses blood biomarkers. In accordance with "Guidelines for Proper Use of Cerebrospinal Fluid and Blood Biomarkers in Dementia"(1), this study aims to demonstrate the utility of blood biomarkers and improve the early diagnosis of Alzheimer's disease within a coordinated system of medical care that encompasses primary care physicians and specialists who are members of dementia-related medical societies.In cases of Alzheimer's disease, which is said to account for more than 60% of dementia cases, amyloid beta (Abeta, a protein thought to cause AD) starts aggregating in the brain around 20 years before AD onset. Positron emission tomography (amyloid PET) and cerebrospinal fluid (CSF) testing are used to estimate the degree of Aβ accumulation in the brain, but only a limited number...

ACN Newswire
Read More

Society Pass (Nasdaq: SOPA)/ NusaTrip Collaborates with Periksa.id to Promote Indonesia’s Wellness, Health, and Medical Tourism Recovery Strategy

indie
7 minutes

SINGAPORE, Nov 22, 2022 - (ACN Newswire via SEAPRWire.com) - Nusatrip, the Indonesia-based Online travel agent (OTA) and travel platform of Society Pass Incorporated ("SoPa") (Nasdaq: SOPA), Southeast Asia's (SEA) leading data-driven loyalty, fintech and e-commerce ecosystem, today announces an official partnership with Periksa.id, a Jakarta-based leading health-tech solutions company, to enable and introduce flight search engine services in over 200 hospitals and clinics across 13 provinces in Indonesia. Periksa's network covers over 200,000 doctors, medical workers, and over 1.5 million daily patients. The partnership strengthens NusaTrip's commitment to developing more vibrant travel services for all consumers, business partners, and stakeholders in Indonesia and throughout SEA.Wellness, Health, and Medical Tourism have been one of the Ministry of Tourism and Creative Economy's strategies for industry revival since the pandemic of COVID-19 hits. According to Future Market Insights Global and Consulting Pvt. Ltd., the global Medical Tourism market is expected to be valued at US$ 5.2 Billion in 2022 and is projected to grow at a CAGR of 30.5% between 2022 and 2032, totaling around...

JCN Newswire
Read More

Fujitsu and Wakayama Medical University start joint trials for millimeter-wave sensor to detect falls of elderly patients

ruth
5 minutes

TOKYO, Nov 21, 2022 - (JCN Newswire via SEAPRWire.com) - Fujitsu and Wakayama Medical University today announced the start of joint trials of a technology to support nurses and caregivers in visually monitoring patients in privacy-sensitive contexts, including hospital rooms and nursing facilities. The technology leverages Fujitsu's technique for accurately estimating postures of the human body using a millimeter-wave sensor and Fujitsu's "Actlyzer"(1) AI technology for analysis of complex human behaviors. Using a millimeter-wave sensor to gather point cloud data and no cameras, Fujitsu's technology will help to support nurses and caregivers to monitor patients and achieve a faster response to emergency situations including falls and possible serious injuries while ensuring patients' privacy.Fujitsu will analyze data obtained through the trials and further refine its technology based on analysis results evaluated by Wakayama Medical University, drawing on the Wakayama Medical University's knowledge from the medical field.Based on these results, the two parties aim to offer a millimeter-wave sensor service for privacy-conscious monitoring to hospitals and nursing facilities in fisca...

ACN Newswire
Read More

Healthcare and Medical Leaders Gather to Shape the Future of Global Health

indie
9 minutes

HONG KONG, Nov 11, 2022 - (ACN Newswire via SEAPRWire.com) - New research and innovations in Hong Kong and the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) are injecting new momentum and creating new opportunities for the regional and global healthcare and medical sectors, as highlighted in the two-day Asia Summit on Global Health (ASGH). The second ASGH and the physical element of the 13th edition of the HKTDC Hong Kong International Healthcare Fair concluded successfully today.The second Asia Summit on Global Health, co-organised by the Hong Kong Special Administrative Region (HKSAR) Government and HKTDC, and the physical part of the 13th HKTDC Hong Kong International Medical and Healthcare Fair conclude successfully today.Kenneth Tsang, CEO of Gleneagles Hospital Hong Kong and Kyle Wong, PanopticAI CEO & Cofounder (R) signed a MOU on digital healthcare solution improvement on the first day of the Summit, witnessed by Patrick Lau, HKTDC Deputy Executive Director (L).As the flagship events of the first International Healthcare Week initiated by the Hong Kong Trade Development Council (HKTDC), the summit and fair attracted close to 30,000 online and physical participants fr...

ACN Newswire
Read More

Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK International Medical and Healthcare Fair

indie
10 minutes

HONG KONG, Nov 10, 2022 - (ACN Newswire via SEAPRWire.com) - Global healthcare collaboration and innovation are key themes of the Hong Kong Trade Development Council (HKTDC)'s inaugural International Healthcare Week, currently taking place at the Hong Kong Convention and Exhibition Centre (HKCEC). The week is comprised of two anchor events: the second Asia Summit on Global Health (ASGH), co-organised with the Government of the Hong Kong Special Administrative Region (HKSAR) and the 13th Hong Kong International Medical and Healthcare Fair.The second Asia Summit on Global Health, co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the HKTDC, runs under the theme "Charting a New Course in Healthcare through Collaboration" today and tomorrow.Dr Zsuzsanna Jakab, Deputy Director-General of the World Health OrganizationCao Xuetao, Vice-Minister of the National Health Commission of the People's Republic of ChinaThe two-day summit kicks off today in hybrid format under the theme of "Charting a New Course in Healthcare through Collaboration", with the second day going online. The 13th International Medical and Healthcare Fair from 9 to 11 November featur...

ACN Newswire
Read More

Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round

indie
5 minutes

HONG KONG, Nov 10, 2022 - (ACN Newswire via SEAPRWire.com) - Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital. This round of funds will mainly be used for the construction of overseas medical device resources, the expansion of the professional talent team, the strategic expansion of the medical devices field, and the upgrading and iteration of the big data information platform.Founded in June 2020, PureFDA is a global-leading SaaS + Data service life science service provider that focuses on whole-process informatization of medical devices going overseas in the global market. Besides, the company is dedicated to providing whole-process consulting services for compliance access to the global market for products such as medical devices, in vitro diagnostics and medical software AI, covering device regulations consultation, local authorized representatives, product certification and registration, overseas clinical trials, technical documentation and system guidance, p...

ACN Newswire
Read More

Handover of National Centre for Pandemic and Infection Diseases in Myanmar; Advanced Facility Built with Donation from AW Foundation

indie
3 minutes

YANGON, Myanmar, Nov 5, 2022 - (ACN Newswire via SEAPRWire.com) - AW Foundation, the philanthropic arm of Asia World Group of Companies, handed over to the Ministry of Health the newly completed Wai Bar Gi New Wing - National Centre for Infectious Diseases on 3rd Nov, 2022. Dedicated to the treatment of infectious diseases and pandemics such as COVID-19 which exerted heavy patient load on the public healthcare sector, it is the most advanced medical centre to date in Myanmar. The Newly-Constructed Wai Bar Gi New Wing- National Centre for Infectious DiseasesSide Views of Wai Bar Gi New Wing- National Centre for Infectious Diseases Interior Views of Wai Bar Gi New Wing- National Centre for Infectious Diseases Lieutenant General Aung Lin Dwe, the secretary of the State Administration Council, unveiled a plaque commemorating the handover of the three-story, 110-bed medical Centre, which was completed with a donation of 6 billion kyats and USD 3.1 million from the Foundation.The Wai Bar Gi New Wing was mooted in November 2020 by the AW Foundation team based on the personal experience of colleagues during the COVID-19 pandemic. The lack of quarantine hospitals, beds, and oxygen supply, a...

ACN Newswire
Read More

Inaugural International Healthcare Week promotes Hong Kong as leading healthcare hub

indie
12 minutes

HONG KONG, Oct 31, 2022 - (ACN Newswire via SEAPRWire.com) - Developments such as the COVID-19 pandemic and a global ageing trend have significantly increased the demand for healthcare products and services. The inaugural International Healthcare Week, driven by Hong Kong Trade Development Council (HKTDC), will run from 1 to 15 November 2022, helping to promote innovation, investment and exchange by fully utilising Hong Kong's strategic role as an innovation and investment hub for Asia's healthcare industry. The two flagship events of International Healthcare Week are the second Asia Summit on Global Health (ASGH) co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the HKTDC, and the 13th edition of the HKTDC Hong Kong International Medical and Healthcare Fair organised by the HKTDC.HKTDC Executive Director Margaret Fong; Prof Lo Yuk-lam, Chairman of GT Healthcare Capital Partners & President of the HK Bio-Med Innotech Association (L); Rupert Mok, Secretary General of Hong Kong Medical and Healthcare Device Industries Association (R)Yuan Hua Technology presents its research results at the press conference.Cellomics Holdings Limited features...